Cytokines alone for PBPC collection in patients with advanced gynaecological malignancies: G-CSF vs G-CSF plus EPO

被引:4
作者
Perillo, A [1 ]
Ferrandina, G
Pierelli, L
Rutella, S
Mancuso, S
Scambia, G
机构
[1] Univ Cattolica Sacro Cuore, Gynaecol Oncol Unit, I-00168 Rome, Italy
[2] ASL Viterbo, Immunohaematol & Transfus Serv, Viterbo, Italy
[3] Univ Cattolica Sacro Cuore, Dept Haematol & Blood Transfus, I-00168 Rome, Italy
[4] Fdn Cassa Risparmio, Cord Blood Stem Cell Project, Rome, Italy
[5] Univ Sacred Heart, Dept Oncol, Campobasso, Italy
关键词
D O I
10.1038/sj.bmt.1704584
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:743 / 744
页数:2
相关论文
共 10 条
[1]  
Akard L P, 1999, Biol Blood Marrow Transplant, V5, P379, DOI 10.1016/S1083-8791(99)70014-5
[2]   FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS [J].
BENSINGER, W ;
APPELBAUM, F ;
ROWLEY, S ;
STORB, R ;
SANDERS, J ;
LILLEBY, K ;
GOOLEY, T ;
DEMIRER, T ;
SCHIFFMAN, K ;
WEAVER, C ;
CLIFT, R ;
CHAUNCEY, T ;
KLARNET, J ;
MONTGOMERY, P ;
PETERSDORF, S ;
WEIDEN, P ;
WITHERSPOON, R ;
BUCKNER, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2547-2555
[3]   Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's lymphoma? [J].
Dazzi, C ;
Cariello, A ;
Rosti, G ;
Argnani, M ;
Sebastiani, L ;
Ferrari, E ;
Zornetta, L ;
Monti, G ;
Nicoletti, P ;
Baioni, M ;
Salvucci, M ;
Scarpi, E ;
Marangolo, M .
LEUKEMIA & LYMPHOMA, 2000, 39 (3-4) :301-310
[4]   Peripheral blood progenitor cell transplantation [J].
Jansen, J ;
Thompson, JM ;
Dugan, MJ ;
Nolan, P ;
Wiemann, MC ;
Birhiray, R ;
Henslee-Downey, PJ ;
Akard, LP .
THERAPEUTIC APHERESIS, 2002, 6 (01) :5-14
[5]   A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF [J].
Knudsen, LM ;
Jensen, L ;
Gaarsdal, E ;
Nikolaisen, K ;
Johnsen, HE .
BONE MARROW TRANSPLANTATION, 2000, 26 (07) :717-722
[6]   Stem cell mobilization with G-CSF alone in breast cancer patients:: higher progenitor cell yield by delivering divided doses (2x5 μg/kg) compared to a single dose (1x10 μg/kg) [J].
Kröger, N ;
Zeller, W ;
Hassan, HT ;
Krüger, W ;
Gutensohn, K ;
Löliger, C ;
Zander, AR .
BONE MARROW TRANSPLANTATION, 1999, 23 (02) :125-129
[7]   Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSF [J].
Perillo, A ;
Pierelli, L ;
Scambia, G ;
Serafini, R ;
Paladini, U ;
Salerno, MG ;
Bonanno, G ;
Fattorossi, A ;
Leone, G ;
Mancuso, S ;
Menichella, G .
TRANSFUSION, 2001, 41 (05) :674-680
[8]   Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: Results of a randomized comparison [J].
Pierelli, L ;
Perillo, A ;
Greggi, S ;
Salerno, G ;
Panici, PB ;
Menichella, G ;
Fattorossi, A ;
Leone, G ;
Mancuso, S ;
Scambia, G .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1288-1295
[9]   High-dose chemotherapy - High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results [J].
Salerno, MG ;
Ferrandina, G ;
Greggi, S ;
Pierelli, L ;
Menichella, G ;
Leone, G ;
Scambia, G ;
Mancuso, S .
BONE MARROW TRANSPLANTATION, 2001, 27 (10) :1017-1025
[10]   Current issues in high-dose chemotherapy and stem cell support - Introduction [J].
Shea, TC .
BONE MARROW TRANSPLANTATION, 1999, 23 (Suppl 2) :S1-S5